Nu-Med Plus, Inc. Advances Blood and Plasma Transfusion Technology with New Patent
14 nov. 2018 12h07 HE
|
Nu-Med Plus Inc.
Nu-Med Plus’ Proprietary Technology Aims to Increase Longevity and Safety of Banked Blood Supply and Reduce Side Effects of Blood Transfusions SALT LAKE CITY, Nov. 14, 2018 (GLOBE NEWSWIRE) --...
Nu-Med Plus, Inc. Announces Strategic Rebrand to Focus on Leading Advancements in the Nitric Oxide Delivery Industry
09 oct. 2018 07h30 HE
|
Nu-Med Plus Inc.
SALT LAKE CITY, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, announces a new articulation of the...
Nu-Med Plus, Inc. Strategically Positioned After Monopoly-Ending Patent Ruling Opens Nitric Oxide Market
14 août 2018 09h00 HE
|
Nu-Med Plus Inc.
Innovative nitric oxide delivery device company predicting vibrant market for its next-generation products SALT LAKE CITY, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB:NUMD), a...
Nu-Med Plus, Inc. engages Millennium Biosciences for Quality and Regulatory consulting services
12 juin 2018 08h00 HE
|
Nu-Med Plus Inc.
SALT LAKE CITY, June 12, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB:NUMD), a medical device company which investigates and develops applications of Nitric Oxide technologies in the medical...
Nu-Med Plus Inc. applies for Innovative Patent on Reactive Tube Coating
05 juin 2018 08h00 HE
|
Nu-Med Plus Inc.
SALT LAKE CITY, June 05, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB:NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field,...